Indication
Emergency treatment of severe capecitabine toxicity
Emergency treatment of severe capecitabine toxicity addresses a critical oncologic complication characterized by acute, life-threatening systemic overexposure to fluoropyrimidines following capecitabine administration. Read more about Emergency treatment of severe capecitabine toxicity
3 drugs 3 manufacturers
Drugs that treat it
Common Emergency treatment of severe capecitabine toxicity therapies.
VISTOGARD (uridine triacetate)
VISTOGARD (uridine triacetate)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonEmergency treatment of severe capecitabine toxicity addresses a critical oncologic complication characterized by acute, life-threatening systemic overexposure to fluoropyrimidines following capecitabine administration.
Capecitabine is an orally administered prodrug of 5-fluorouracil, and profound toxicity typically arises from accidental overdose or impaired clearance due to dihydropyrimidine dehydrogenase (DPD) enzyme deficiency.
This clinical state affects adult and pediatric cancer patients, manifesting as early-onset, rapidly progressive dysfunction across multiple organ systems, most notably cardiovascular collapse, central nervous system impairment, refractory gastrointestinal injury such as severe mucositis or diarrhea, and profound neutropenia.
Immediate intervention aims to arrest cellular injury and prevent fatal multiorgan failure by mitigating the toxic incorporation of fluorinated metabolites into cellular RNA and DNA.
- fda.gov
Emergency treatment of severe capecitabine toxicity addresses a critical oncologic complication characterized by acute, life-threatening systemic overexposure to fluoropyrimidines following capecitabine administration
- eviq.org.au
Emergency treatment of severe capecitabine toxicity addresses a critical oncologic complication characterized by acute, life-threatening systemic overexposure to fluoropyrimidines following capecitabine administration This clinical state affects adult and pediatric cancer patients, manifesting as early-onset, rapidly progressive dysfunction across multiple organ systems, most notably cardiovascular collapse, central nervous system impairment, refractory gastrointestinal injury such as severe muc...
- nih.gov
Capecitabine is an orally administered prodrug of 5-fluorouracil, and profound toxicity typically arises from accidental overdose or impaired clearance due to dihydropyrimidine dehydrogenase (DPD) enzyme deficiency Immediate intervention aims to arrest cellular injury and prevent fatal multiorgan failure by mitigating the toxic incorporation of fluorinated metabolites into cellular RNA and DNA
- jons-online.com
Capecitabine is an orally administered prodrug of 5-fluorouracil, and profound toxicity typically arises from accidental overdose or impaired clearance due to dihydropyrimidine dehydrogenase (DPD) enzyme deficiency
- fda.gov
This clinical state affects adult and pediatric cancer patients, manifesting as early-onset, rapidly progressive dysfunction across multiple organ systems, most notably cardiovascular collapse, central nervous system impairment, refractory gastrointestinal injury such as severe mucositis or diarrhea, and profound neutropenia
- fda.gov
This clinical state affects adult and pediatric cancer patients, manifesting as early-onset, rapidly progressive dysfunction across multiple organ systems, most notably cardiovascular collapse, central nervous system impairment, refractory gastrointestinal injury such as severe mucositis or diarrhea, and profound neutropenia
- jhoponline.com
Immediate intervention aims to arrest cellular injury and prevent fatal multiorgan failure by mitigating the toxic incorporation of fluorinated metabolites into cellular RNA and DNA
Personalize your experience
Follow Emergency treatment of severe capecitabine toxicity and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.